A 73-Year-Old Male With Mantle Cell Lymphoma

Brian Hill, MD, reviews the case of a 73-year-old man with mantle cell lymphoma.

Brian Hill, MD, reviews frontline treatment options for patients with mantle cell lymphoma.

Brian Hill, MD, reviews second-line treatment options for patients with relapsed/refractory mantle cell lymphoma.

Brian Hill, MD, reviews practice-changing data from the ZUMA-2 trial in patients with relapsed/refractory mantle cell lymphoma.

Brian Hill, MD, reviews strategies for mitigating toxicities associated with CAR T-cell therapy.

Brian Hill, MD, reviews the role of CAR T-cell therapy in mantle cell lymphoma.

Brian Hill, MD, reviews unmet needs and future directions in the management of mantle cell lymphoma.